Taylor Sandison
2018
In 2018, Taylor Sandison earned a total compensation of $678.5K as Chief Medical Officer at Cidara Therapeutics, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $109,500 |
|---|---|
| Option Awards | $196,994 |
| Salary | $372,000 |
| Total | $678,494 |
Sandison received $372K in salary, accounting for 55% of the total pay in 2018.
Sandison also received $109.5K in non-equity incentive plan and $197K in option awards.
Rankings
In 2018, Taylor Sandison's compensation ranked 10,834th out of 14,244 executives tracked by ExecPay. In other words, Sandison earned more than 23.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,834 out of 14,244 | 24th |
Division Manufacturing | 4,372 out of 5,765 | 24th |
Major group Chemicals And Allied Products | 1,649 out of 2,128 | 23rd |
Industry group Drugs | 1,398 out of 1,817 | 23rd |
Industry Biological Products, Except Diagnostic Substances | 269 out of 339 | 21st |
Source: SEC filing on April 26, 2019.
Sandison's colleagues
We found three more compensation records of executives who worked with Taylor Sandison at Cidara Therapeutics in 2018.
News
Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M
June 3, 2024
Cidara Therapeutics CEO Jeffrey Stein's 2022 pay falls 23% to $1.3M
April 27, 2023
Cidara Therapeutics CEO Jeffrey Stein's 2021 pay jumps 26% to $1.6M
April 29, 2022
Cidara Therapeutics CEO Jeffrey Stein's 2019 pay rises 6% to $1.5M
April 29, 2020
Cidara Therapeutics CEO Jeffrey Stein's 2018 pay falls 25% to $1.4M
April 26, 2019